Dyspepsia and Helicobacter pylori infection among employees of a large company - Results of a prospective evaluation;Dyspepsie und Helicobacter-pylori-infektion bei beschäftigten eines großen industrieunternehmens

Medizinische Klinik

Volumn 97, Issue 1, 2002, Pages 6-11

  Schilling, Dieter ^a   Messerer, Peter ^b   Ott, M G Gerald ^c   Schauwecker, Peter ^a   Zober, Andreas ^b   Riemann, Jürgen F ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b Abteilung Arbeitsmedizin und Gesundheitsschutz   (Germany)

^c BASF CORPORATION   (United States)

Author keywords

Dyspepsia; Helicobacter pylori infection; Occupational medicine

Indexed keywords

ADULT; ARTICLE; BACTERIAL VIRULENCE; DYSPEPSIA; EMPLOYEE; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL DISEASE; OCCUPATIONAL MEDICINE; PROGNOSIS; PROSPECTIVE STUDY; SEROPREVALENCE; UPPER GASTROINTESTINAL TRACT;

ADOLESCENT; ADULT; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; GASTRITIS; GERMANY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MASS SCREENING; METRONIDAZOLE; MIDDLE AGED; OCCUPATIONAL DISEASES; OMEPRAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 18244408041     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1118-z     Document Type: Article

References (26)

1. Evaluation of dyspepsia
2. Non ulcer dyspepsia and peptic ulcer: The distribution in a population and their relation to risk
3. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia
4. Molecular characterization of the 128kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer
5. Expression of the 120 kDa protein and cytotoxicity in helicobacter pylori
6. Gastric mucosal inflammatory responses to Helicobacter pylori
7. The Glasgow Dyspepsia Severity Score - A tool for global assessment of dyspepsia
8. Definitions of dyspepsia
9. Usefulness of anti helicobacter and anti CagA antibodies in the selection of patients for gastroscopy
10. Dyspepsia in healthy blood donors. Pattern of symptoms and association with helicobacter pylori
11. Antibody response to specific H. pylori antigens in functional dyspesia, duodenal ulcer disease and health
12. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review
13. Symptomatic benefit from eradicating Helicobacter infection in patients with non-ulcer dyspepsia
14. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: A randomised controlled trial
15. Dyspepsia in community is linked to smoking and Aspirin use but not to H. pylori infection
16. Helicobacter pylori infection and gastric lymphoma
17. The Sydney system: Histological division
18. Relation between Helicobacter pylori infection and syndromes of dyspepsia
19. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 month's follow up
20. Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia
21. Non ulcer dyspepsia in a Dutch working population and Helicobacter pylori
22. Lack of correlation between self reported symptoms of dyspepsia and infection with helicobacter pylori, in a general population sample
23. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
24. Helicobacter pylori in functional dyspepsia and normal controls
25. Helicobacter pylori infection: Prevalence and clinical significance in a large company
26. Helicobacter pylori (Hp)-infektion: Prävalenz und klinische bedeutung sowie effekt der eradikationstherapie